etoposide has been researched along with Acquired Immune Deficiency Syndrome in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (15.15) | 18.7374 |
| 1990's | 13 (39.39) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 3 (9.09) | 24.3611 |
| 2020's | 5 (15.15) | 2.80 |
| Authors | Studies |
|---|---|
| Bassett, IV; Busakhala, N; Byakwaga, H; Freedberg, KA; Freeman, EE; Hajny Fernandez, ME; Hyle, EP; Kiprono, S; Laker-Oketta, M; Martin, JN; Maurer, T; McCann, NC; Pei, PP; Reddy, KP; Semeere, A | 1 |
| Argy, N; Debus, J; Guiraud, V; Herbel, S; Ricard, JD; Roux, D; Tetelboum, N; Thy, M; Verney, C; Zucman, N | 1 |
| Agarwal, A; Alahari, A; Bagal, B; Gota, V; Gujral, S; Gupta, H; Jain, H; Kannan, S; Kumar, S; Laskar, SS; Menon, H; Nayak, L; Rangarajan, V; Sengar, M; Sharma, N; Shet, T; Sridhar, E; Thorat, J | 1 |
| Borok, M; Bukuru, A; Busakhala, N; Campbell, TB; Chang, D; Epeldegui, M; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kang, M; Kanyama, C; Krown, SE; Langat, D; Lee, J; Magpantay, LI; Martínez-Maza, O; Mngqibisa, R; Mwelase, N; Nyirenda, M; Samaneka, W | 1 |
| Allione, B; Calimeri, T; Cattaneo, C; Donadoni, G; Facchetti, F; Ferrari, D; Ferreri, AJM; Foppoli, M; Fumagalli, L; Lleshi, A; Pecciarini, L; Ponzoni, M; Re, A; Rigacci, L; Rossi, G; Sassone, M; Spina, M; Verga, L | 1 |
| Arora, N; Gupta, A; Sadeghi, N | 1 |
| Ambinder, RF; Epeldegui, M; Lee, JY; Magpantay, LI; Martínez, AC; Martínez-Maza, O; Mitsuyasu, R; Regidor, D; Sparano, JA; Widney, DP | 1 |
| Blankenship, DW; Mauskar, MM; Nymeyer, H | 1 |
| Cooley, TP; Evans, SR; Krown, SE; Testa, MA; Von Roenn, JH | 1 |
| Franchini, G; Grant, N; Gutierrez, M; Jaffe, ES; Kavlick, MF; Little, RF; Mitsuya, H; Pittaluga, S; Raffeld, M; Shearer, G; Steinberg, SM; Wilson, WH; Yarchoan, R | 1 |
| Aboulafia, DM; Waddington, TW | 1 |
| Borok, M; Cheang, M; Clinch, J; Gudza, I; Kiire, CF; Levy, L; Nyamasve, J; Olweny, CL; Otim-Oyet, D; Schipper, H | 1 |
| Abella, E; Brunet, S; del Potro, E; Esteve, J; Oriol, A; Ribera, JM | 1 |
| Volberding, P | 1 |
| Bennett, JM; Feldstein, ML; Kahn, JO; Krown, SE; Lin, S; Metroka, CE; Paredes, J; Ratner, L; Tong, WP | 1 |
| Aisner, J; Belani, CP; Doyle, LA | 1 |
| Muggia, FM | 1 |
| Becker, N; Leaf, A; Sparano, JA; Strack, M; Valentine, ES; Wiernik, PH | 1 |
| Anderson, PM; Skubitz, KM | 1 |
| Byrnes, JJ; Cabral, L; Fletcher, MA; Freidlander, A; Harrington, WJ; Patarca, R | 1 |
| Ekman, K; Hilstro, J; Horton, J; Reddy, M; Remick, SC; Vyzula, R | 1 |
| Dutcher, JP; Henry, DH; Hu, X; Mason, B; Ratech, H; Sarta, C; Schwartz, EL; Soeiro, R; Sparano, JA; Wiernik, PH | 1 |
| Di Leone, L; Gerhardt, L; Kalakun, L; Kromfield, M; Mans, DR; Prolla, G; Sander, E; Schwartsmann, G; Sprinz, E | 1 |
| Ishizaka, K; Kageyama, Y; Kihara, K; Nagai, H; Oshima, H; Tosaka, A; Tsujii, T | 1 |
| Douglas, R; Michael, B; Nabil, S; Thomas, F | 1 |
| Caldas, AP; Cancela, A; Dalla Costa, T; DiLeone, L; Mans, DR; Schwartsmann, G; Sprinz, E | 1 |
| Bouabdallah, R; Dhiver, C; Gastaut, JA; Giovannini, M; Lafeuillade, A; Poizot-Martin, I; Quilichini, R; Viallat, JR | 1 |
| Hughes-Davies, LT; Murray, P; Spittle, M | 1 |
| Volberding, PA | 1 |
| Bachelez, H; Revuz, J | 1 |
| Kaplan, LD; Volberding, PA | 1 |
| Andes, WA; Grace, W; Green, MD; Gupta, S; Kempf, R; Krigel, RL; Lonberg, M; Muggia, FM; Slywotzky, CM; Spiegel, RJ | 1 |
3 review(s) available for etoposide and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Etoposide: current status and future perspectives in the management of malignant neoplasms.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Germinoma; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Sarcoma, Kaposi; Stomach Neoplasms | 1994 |
Teniposide: overview of its therapeutic potential in adult cancers.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Etoposide; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoma, Kaposi; Teniposide | 1994 |
Treatment of AIDS and its attendant malignancies.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease Susceptibility; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Sarcoma, Kaposi; Vinblastine; Vincristine; Zidovudine | 1989 |
13 trial(s) available for etoposide and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Prednisone; Vinblastine; Vincristine | 2023 |
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Transplantation, Autologous | 2021 |
Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytokines; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphocyte Activation; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine | 2016 |
Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Etoposide; Female; Humans; Male; Quality of Life; Sarcoma, Kaposi; Survival Analysis; Treatment Outcome | 2002 |
Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Male; Palliative Care; Quality of Life; Radiotherapy; Sarcoma, Kaposi; Surveys and Questionnaires; Treatment Outcome; Zimbabwe | 2005 |
Therapy of Kaposi's sarcoma in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Humans; Immunotherapy; Interferon Type I; Interleukin-2; Prognosis; Research Design; Sarcoma, Kaposi; Vinblastine | 1984 |
Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Tolerance; Etoposide; HIV Infections; HIV-1; Humans; Male; Sarcoma, Kaposi | 1995 |
Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Double-Blind Method; Doxorubicin; Etoposide; Female; Fluorouracil; Glutamine; Humans; Ifosfamide; Male; Neoplasms; Pilot Projects; Placebos; Sarcoma, Kaposi; Stomatitis; Vincristine | 1996 |
Peripheral blood T cell subsets as prognostic indicators of chemotherapy outcome in AIDS patients with large cell lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Didanosine; Doxorubicin; Etoposide; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Treatment Outcome; Vincristine | 1996 |
Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Humans; Infusions, Intravenous; Male; Neoplasm Staging; Sarcoma, Kaposi | 1996 |
Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neutropenia; Sarcoma, Kaposi | 1997 |
Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Area Under Curve; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Sarcoma, Kaposi | 2001 |
Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Sarcoma, Kaposi | 1988 |
17 other study(ies) available for etoposide and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis.
Topics: Acquired Immunodeficiency Syndrome; Bleomycin; Cost-Benefit Analysis; Etoposide; HIV Infections; Humans; Kenya; Paclitaxel; Sarcoma, Kaposi; Vincristine | 2022 |
Life-threatening hemophagocytic syndrome triggered by disseminated toxoplasmosis in a young patient with previously unknown AIDS.
Topics: Acquired Immunodeficiency Syndrome; Etoposide; HIV Infections; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Toxoplasmosis | 2022 |
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.
Topics: Acquired Immunodeficiency Syndrome; Biomarkers; Chemoradiotherapy; Etoposide; HIV Infections; Humans; Inflammation; Interleukin-10; Ligands; Matrix Metalloproteinase 2; Receptors, Tumor Necrosis Factor; Resource-Limited Settings; Sarcoma, Kaposi; Vascular Endothelial Growth Factor A | 2023 |
Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Induction Chemotherapy; Male; Plasmablastic Lymphoma; Prednisone; Vincristine | 2017 |
Cutaneous Ulcers Secondary to Cytomegalovirus and Herpes Simplex Virus in an Immunocompromised Patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Doxorubicin; Etoposide; Herpes Simplex; Humans; Immunocompromised Host; Male; Rituximab; Simplexvirus; Skin Ulcer | 2017 |
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Drug Resistance, Viral; Etoposide; Female; HIV Reverse Transcriptase; Humans; Immunohistochemistry; Leukocyte Common Antigens; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mutation; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; T-Lymphocytes; Treatment Outcome; Vincristine; Viral Load | 2003 |
Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Carboplatin; CD4 Lymphocyte Count; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunophenotyping; Lymphoma, AIDS-Related; Male; Middle Aged; Pleural Effusion, Malignant; Prednisone; Salvage Therapy; Sarcoma, Kaposi; Skin Neoplasms; Stem Cell Transplantation; Transplantation, Autologous; Treatment Failure; Vincristine; Viral Load | 2004 |
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Leukemia; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 2005 |
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV; HIV Infections; HIV Seropositivity; HTLV-I Infections; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Analysis; Time Factors | 1993 |
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Didanosine; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; HIV; HIV Core Protein p24; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Survival Rate; Viremia | 1996 |
Hundreds enrolled in canadian HIV trials.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; HIV Protease Inhibitors; Humans; Isoquinolines; Nelfinavir; Prednisone; Randomized Controlled Trials as Topic; Ritonavir; Sulfonic Acids; Vincristine; Zidovudine | 1997 |
Advanced testicular germ cell tumor in a hemophilic patient with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; CD4 Lymphocyte Count; Cisplatin; Combined Modality Therapy; Didanosine; Drug Therapy, Combination; Etoposide; Factor VIII; Germinoma; Hemophilia A; Humans; Male; Orchiectomy; Saquinavir; Testicular Neoplasms; Zidovudine | 1998 |
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors | 2001 |
[Kaposi's sarcoma in AIDS. 70 cases].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bisexuality; Bleomycin; Etoposide; Follow-Up Studies; Homosexuality; Humans; Interferon Type I; Male; Middle Aged; Sarcoma, Kaposi | 1991 |
Fournier's gangrene: a hazard of chemotherapy in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Etoposide; Fasciitis; Gangrene; Humans; Male; Necrosis; Neutropenia; Perineum; Sarcoma, Kaposi; Scrotum; Skin Neoplasms | 1991 |
The role of chemotherapy for epidemic Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Humans; Methotrexate; Sarcoma, Kaposi; Vinblastine; Vincristine | 1987 |
[Treatment of Kaposi's disease].
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Interferons; Sarcoma, Kaposi; Vinca Alkaloids | 1989 |